Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0326-2027

Senographe Pristina Recall

Senographe Pristina

FDA recall Class II

Ongoing

FDA lists this Class II recall for Senographe Pristina. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0326-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 28, 2026
FDA report date
Nov 11, 2026
Quantity in commerce
Not reported
Distribution
See key details
FDA cause
Radiation Control for Health and Safety Act

What is being recalled?

Senographe Pristina

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

GTIN(s): 00840682118460, 00840682142052, 00840682145879, 00195278022745, 00195278276971, 00195278661999, 00195278665379, 00195278914026, 00198953109281, 10198953054311, 10195278901764.

View the original FDA recall notice

Why was this product recalled?

GE HealthCare has become aware of a nonconformance to certain Senographe Pristina VIA systems. Specifically, in cases of 3D+2D manual mode where the acquisition configuration of the anode track/filter combination is different, it can result in the following: the collimator blades might be visible in the image, or the collimator might be open more than expected, and an incorrect collimator filter might be used with respect to the anode track selected This issue could result in a minor additional X-ray dose being delivered to the patient and obvious artifacts in the image (collimator blades).

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did GE Medical Systems, LLC take?

GE HealthCare will send a customer letter dated August 28, 2026, that provides safety instructions for immediate mitigation of the incorrect configuration of the collimator anode track / filter in manual mode during 3D+2D acquisitions. GE HealthCare will correct all affected Senographe Pristina VIA systems by upgrading the software at no cost to the customer. If you have any questions or concerns regarding this notification, please contact GE HealthCare Service at 1-800-437-1171 or your local Service Representative.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology